Abstract
摘要
相似文献
1
Antifibrinolytics.抗纤维蛋白溶解剂
Acta Anaesthesiol Belg. 2003;54(4):319-22.
2
Antifibrinolytics in liver transplantation.肝移植中的抗纤溶药物
Int Anesthesiol Clin. 2006 Summer;44(3):83-97. doi: 10.1097/01.aia.0000210804.39545.66.
3
Current status of non-transfusional haemostatic agents.非输血性止血剂的现状
Haematologica. 1999 Jun;84 Suppl EHA-4:120-3.
4
Natural and synthetic antifibrinolytics: inert, poisonous or therapeutic agents?
Can J Anaesth. 1997 Sep;44(9):913-7. doi: 10.1007/BF03011960.
5
The post-BART anti-fibrinolytic dilemma?球囊扩张后抗纤溶的困境？
J Cardiothorac Vasc Anesth. 2011 Feb;25(1):3-5. doi: 10.1053/j.jvca.2010.11.018.
6
Hemostatic drugs.止血药物。
N Engl J Med. 1998 Jul 23;339(4):245-53. doi: 10.1056/NEJM199807233390407.
7
ε-Aminocaproic acid and clinical value in cardiac anesthesia.ε-氨基己酸在心脏麻醉中的临床价值。
J Cardiothorac Vasc Anesth. 2011 Feb;25(1):16-9. doi: 10.1053/j.jvca.2010.07.024. Epub 2010 Sep 25.
8
The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery.抑肽酶与氨甲环酸在心脏手术中的风险效益比。
Anesth Analg. 2010 Jan 1;110(1):21-9. doi: 10.1213/ANE.0b013e3181c0ea6d. Epub 2009 Nov 12.
9
Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.氨甲环酸与抑肽酶在心脏初次手术中的应用：对220例接受氨甲环酸或抑肽酶治疗的心脏手术患者的分析
Anesth Analg. 2008 Nov;107(5):1469-78. doi: 10.1213/ane.0b013e318182252b.
10
[Hemostasis and antifibrinolytic therapy in major pediatric surgery].[小儿大手术中的止血与抗纤溶治疗]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2013 Jul;48(7-8):454-61; quiz 462. doi: 10.1055/s-0033-1352490. Epub 2013 Aug 8.
Zotero 插件